The Oncology Learning Network Great Debates in Solid Tumors conference will hold its second 2026 installment from September 26–27 in New York City. Organized by HMP Global, this meeting serves […]

The 68th ASTRO Annual Meeting of the American Society for Radiation Oncology will be held from September 26 to September 30, 2026, in Boston, Massachusetts, with both in-person and on-demand […]

The Society for Integrative Oncology 23rd International Conference is a hybrid scientific symposium scheduled for September 29 - October 1, 2026, in Detroit, Michigan. Hosted in collaboration with the Henry Ford […]

The 2026 International Symposium of Gastrointestinal Oncology (ISGIO), hosted by Physicians’ Education Resource, LLC, will be held from October 2–3, 2026, at the W Fort Lauderdale in Florida. This premier two-day multidisciplinary conference is dedicated to the latest breakthroughs in gastrointestinal (GI) cancer research and the evolving treatment landscape. Led by program co-chairs Dr. Tanios […]

The 29th British Oncology Pharmacy Association (BOPA) Annual Conference is a key scientific meeting for oncology pharmacy professionals, scheduled for October 2–4, 2026, at the ICC London Olympia. The symposium focuses on the technical and clinical advancements in cancer pharmacy, featuring a peer-reviewed scientific program that covers therapeutic updates, service delivery innovation, and clinical research […]

The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao, Spain, from October 6–8, 2026. This conference focuses on metabolic reprogramming, a key hallmark of tumors, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands, survive in hostile environments, and modify their niche. The […]

The Early Detection of Cancer Conference 2026 is set to convene from October 6–8 at the Edinburgh International Conference Centre (EICC) in Scotland. Co-hosted by Cancer Research UK and the OHSU Knight Cancer Institute, this premier three-day summit serves as a global focal point for the International Alliance for Cancer Early Detection (ACED). The program […]

The 2nd Australasian International Breast Congress (AIBC) will take place in Brisbane, Australia, from October 8–10, 2026, bringing together the Australasian Society for Breast Disease (ASBD), the World Congress on […]

The 2026 NFCR Global Summit and Award Ceremonies for Cancer Research and Entrepreneurship is a high-impact annual gathering hosted by the National Foundation for Cancer Research (NFCR) where science and […]

The conference "Innovative Preclinical Models for Pediatric Cancer Research" (DMM26) is a specialized scientific meeting scheduled for October 13–15, 2026. Organized by the Company of Biologists, this event focuses on […]

The ASCO Quality Care Symposium 2026 is a hybrid medical conference dedicated to advancing the quality of cancer care. The meeting will be held from October 16–17, 2026, both in-person […]

The ESMO Congress 2026 will take place from 23–27 October in Madrid, Spain, bringing together oncology professionals from around the world. This global event serves as a key platform for presenting groundbreaking research, advancing clinical practice, and shaping patient care in oncology. Attendees can expect new data releases, interactive educational sessions, networking opportunities, and an […]

The 2026 NCODA International Fall Summit is a premier educational event for the global oncology community, scheduled for October 28–30, 2026, in Orlando, Florida. The summit is designed to foster innovation in patient-centered care and medically integrated oncology, bringing together clinical experts, pharmacists, and industry partners. Participants can engage in over 40 technical sessions covering […]

The European Association for Cancer Research (EACR) conference, "Chromosomes in Crisis: From Chromosomal Instability to Catastrophes in Cancer Genomes," will take place in Berlin, Germany, from November 3–5, 2026. The conference will bring together experts to explore the mechanisms, consequences, and therapeutic vulnerabilities associated with large-scale genomic rearrangements in cancer. The educational focus is on […]